Teleflex | TFX - Sales Revenues


Teleflex reported $570.3M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Align Technology USD 1.02B 40M Sep/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
AtriCure USD 153.6M 12.4M Jun/2026
Baxter International USD 2.98B 20M Sep/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Boston Scientific USD 5.14B 300M Sep/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
Dexcom USD 1.31B 120M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
General Electric Aerospace USD 14.12B 1.49B Sep/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Haemonetics USD 339M 7M Jun/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
J&J USD 25.4B 89M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Merit Medical Systems USD 418.8M 36.9M Jun/2026
Orthofix International USD 219.91M 14.28M Dec/2025
ResMed USD 1.46B 60M Jun/2026
Steris USD 1.5B 90M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026